Gallic acid leads to cell death of Candida albicans by the apoptosis mechanism

References

• 1. Mukherjee PK, Sendid B, Hoarau G, Colombel JF, Poulain D, Ghannoum MA. Mycobiota in gastrointestinal diseases. Nat. Rev. Gastroenterol. Hepatol. 12(2), 77–87 (2015).
  MedlineGoogle Scholar
• 2. Rodrigues ME, Silva S, Azeredo J, Henriques M. Novel strategies to fight Candida species infection. Crit. Rev. Microbiol. 42(4), 594–606 (2016).
  Medline CASGoogle Scholar
• 3. Tsay SV, Mu Y, Williams S et al. Burden of Candidemia in the United States, 2017. Clin. Infect. Dis. 71(9), e449–e453 (2020).
  MedlineGoogle Scholar
• 4. Benedict K, Jackson BR, Chiller T, Beer KD. Estimation of direct healthcare costs of fungal diseases in the United States. Clin. Infect. Dis. 68(11), 1791–1797 (2019).
  MedlineGoogle Scholar
• 5. Bhattacharya S, Sae-Tia S, Fries BC. Candidiasis and mechanisms of antifungal resistance. Antibiotics 9(6), 1–19 (2020).
  Google Scholar
• 6. Lu M, Li T, Wan J, Li X, Yuan L, Sun S. Antifungal effects of phytocompounds on Candida species alone and in combination with fluconazole. Int. J. Antimicrob. Agents 49(2), 125–136 (2017).
  Medline CASGoogle Scholar
• 7. Teodoro GR, Ellepola K, Seneviratne CJ, Koga-Ito CY. Potential use of phenolic acids as anti-Candida agents: a review. Front. Microbiol. 6(DEC), 1–11 (2015).
  MedlineGoogle Scholar
• 8. Bai J, Zhang Y, Tang C et al. Gallic acid: pharmacological activities and molecular mechanisms involved in inflammation-related diseases. Biomed. Pharmacother. 133(2020), 110985 (2021).
  Medline CASGoogle Scholar
• 9. Nabavi SF, Habtemariam S, Di Lorenzo A et al. Post-stroke depression modulation and in vivo antioxidant activity of gallic acid and its synthetic derivatives in a murine model system. Nutrients 8(5), 248 (2016).
  Google Scholar
• 10. Kahkeshani N, Farzaei F, Fotouhi M et al. Pharmacological effects of gallic acid in health and disease: a mechanistic review. Iran. J. Basic Med. Sci. 22(3), 225–237 (2019).
  MedlineGoogle Scholar
• 11. Subramanian AP, John AA, Vellayappan MV et al. Gallic acid: prospects and molecular mechanisms of its anticancer activity. RSC Adv. 5(45), 35608–35621 (2015).
  CASGoogle Scholar
• 12. Shabani S, Rabiei Z, Amini-Khoei H. Exploring the multifaceted neuroprotective actions of gallic acid: a review. Int. J. Food Prop. 23(1), 736–752 (2020).
  CASGoogle Scholar
• 13. Zhu L, Gu PQ, Shen H. Gallic acid improved inflammation via NF-κB pathway in TNBS-induced ulcerative colitis. Int. Immunopharmacol. 67(2018), 129–137 (2019).
  Medline CASGoogle Scholar
• 14. Badhani B, Sharma N, Kakkar R. Gallic acid: a versatile antioxidant with promising therapeutic and industrial applications. RSC Adv. 5(35), 27540–27557 (2015).
  CASGoogle Scholar
• 15. Fujita KI, Kubo I. Antifungal activity of octyl gallate. Int. J. Food Microbiol. 79(3), 193–201 (2002).
  Medline CASGoogle Scholar
• 16. Savi LA, Leal PC, Vieira TO et al. Evaluation of anti-herpetic and antioxidant activities, and cytotoxic and genotoxic effects of synthetic alkyl-esters of gallic acid. Arzneimittelforschung 55(1), 66–75 (2005).
  Medline CASGoogle Scholar
• 17. Kang MS, Oh JS, Kang IC, Hong SJ, Choi CH. Inhibitory effect of methyl gallate and gallic acid on oral bacteria. J. Microbiol. 46(6), 744–750 (2008).
  Medline CASGoogle Scholar
• 18. Kang J, Liu L, Liu M, Wu X, Li J. Antibacterial activity of gallic acid against Shigella flexneri and its effect on biofilm formation by repressing mdoH gene expression. Food Control 94(July), 147–154 (2018).
  CASGoogle Scholar
• 19. Lima VN, Oliveira-Tintino CDM, Santos ES et al. Antimicrobial and enhancement of the antibiotic activity by phenolic compounds: gallic acid, caffeic acid and pyrogallol. Microb. Pathog. 99, 56–61 (2016).
  Medline CASGoogle Scholar
• 20. Borges A, Ferreira C, Saavedra MJ, Simões M. Antibacterial activity and mode of action of ferulic and gallic acids against pathogenic bacteria. Microb. Drug Resist. 19(4), 256–265 (2013).
  Medline CASGoogle Scholar
• 21. Li ZJ, Liu M, Dawuti G et al. Antifungal activity of gallic acid in vitro and in vivo. Phyther. Res. 31(7), 1039–1045 (2017).
  Medline CASGoogle Scholar
• 22. Nguyen DMC, Seo DJ, Lee HB et al. Antifungal activity of gallic acid purified from Terminalia nigrovenulosa bark against Fusarium solani. Microb. Pathog. 56, 8–15 (2013).
  Medline CASGoogle Scholar
• 23. Kasture VS, Katti SA, Mahajan D, Wagh R, College MGVP. Antioxidant and antiparkinson activity of gallic acid derivatives. Pharmacologyonline 1, 385–395 (2009).
  Google Scholar
• 24. AL Zahrani NA, El-Shishtawy RM, Asiri AM. Recent developments of gallic acid derivatives and their hybrids in medicinal chemistry: a review. Eur. J. Med. Chem. 204, 112609 (2020).
  MedlineGoogle Scholar
• 25. Clinical and Laboratory Standards Institute (CLSI) M27-A3. Reference method for broth dilution. Ref. method broth dilution Antifung. susceptibility Test. yeasts. Approv. Stand. 3th ed. 28(14), (2008). https://clsi.org/media/1897/m27ed4_sample.pdf
  Google Scholar
• 26. Clinical Laboratory Standard Institute-CLSI. CLSI M27-S4. In: Reference Method For Broth Dilution Antifungal Susceptibility Testing Of Yeasts, Fourth Informational Supplement (2012).
  Google Scholar
• 27. Odds FC. Synergy, antagonism, and what the chequerboard puts between them. J. Antimicrob. Chemother. 52(1), 1 (2003).
  Medline CASGoogle Scholar
• 28. Da Silva CR, De Andrade Neto JB, Costa Sidrim JJ et al. Synergistic effects of amiodarone and fluconazole on Candida tropicalis resistant to fluconazole. Antimicrob. Agents Chemother. 57(4), 1691–1700 (2013).
  MedlineGoogle Scholar
• 29. Neto JBA, Da Silva CR, Neta MAS et al. Antifungal activity of naphthoquinoidal compounds in vitro against fluconazole-resistant strains of different Candida species: a special emphasis on mechanisms of action on Candida tropicalis. PLoS ONE 9(5), 1–10 (2014).
  Google Scholar
• 30. Da Silva AR, De Andrade Neto JB, Da Silva CR et al. Berberine antifungal activity in fluconazole-resistant pathogenic yeasts: action mechanism evaluated by flow cytometry and biofilm growth inhibition in Candida spp. Antimicrob. Agents Chemother. 60(6), 3551–3557 (2016).
  MedlineGoogle Scholar
• 31. Bagla VP, McGaw LJ, Elgorashi EE, Eloff JN. Antimicrobial activity, toxicity and selectivity index of two biflavonoids and a flavone isolated from Podocarpus henkelii (Podocarpaceae) leaves. BMC Complement. Altern. Med. 14(1), 2–7 (2014).
  MedlineGoogle Scholar
• 32. Lee H, Lee DG. Novel approaches for efficient antifungal drug action. J. Microbiol. Biotechnol. 28(11), 1771–1781 (2018).
  Medline CASGoogle Scholar
• 33. Shi L, Günther S, Hübschmann T, Wick LY, Harms H, Müller S. Limits of propidium iodide as a cell viability indicator for environmental bacteria. Cytom. Part A 71(8), 592–598 (2007).
  Google Scholar
• 34. Crowley LC, Scott AP, Marfell BJ, Boughaba JA, Chojnowski G, Waterhouse NJ. Measuring cell death by propidium iodide uptake and flow cytometry. Cold Spring Harb. Protoc. 2016(7), 647–651 (2016).
  Google Scholar
• 35. Mayer B, Oberbauer R. Mitochondrial regulation of apoptosis. News Physiol. Sci. 18(3), 89–94 (2003).
  Medline CASGoogle Scholar
• 36. Carraro M, Bernardi P. Calcium and reactive oxygen species in regulation of the mitochondrial permeability transition and of programmed cell death in yeast. Cell Calcium 60(2), 102–107 (2016).
  Medline CASGoogle Scholar
• 37. Inoue M, Sakaguchi N, Isuzugawa K, Tani H, Ogihara Y. Role of reactive oxygen species in gallic acid-induced apoptosis. Biol. Pharm. Bull. 23(10), 1153–1157 (2000).
  Medline CASGoogle Scholar
• 38. You BR, Kim SZ, Kim SH, Park WH. Gallic acid-induced lung cancer cell death is accompanied by ROS increase and glutathione depletion. Mol. Cell. Biochem. 357(1–2), 295–303 (2011).
  Medline CASGoogle Scholar
• 39. Semighini CP, Harris SD. Methods to detect apoptotic-like cell death in filamentous fungi. Methods Mol. Biol. 638, 269–279 (2010).
  Medline CASGoogle Scholar
• 40. Locatelli C, Filippin-Monteiro FB, Creczynski-Pasa TB. Alkyl esters of gallic acid as anticancer agents: a review. Eur. J. Med. Chem. 60, 233–239 (2013).
  Medline CASGoogle Scholar
• 41. Inoue M, Suzuki R, Sakaguchi N et al. Selective induction of cell death in cancer cells by gallic acid. Biol. Pharm. Bull. 18(11), 1526–1530 (1995).
  Medline CASGoogle Scholar
• 42. Giordani B, Basnet P, Mishchenko E, Luppi B, škalko-Basnet N. Utilizing liposomal quercetin and gallic acid in localized treatment of vaginal Candida infections. Pharmaceutics 12(1), 1–21 (2020).
  Google Scholar